Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews

被引:0
作者
Farhoudian, Ali [1 ]
Razaghi, Emran [1 ]
Hooshyari, Zahra [2 ]
Noroozi, Alireza [3 ]
Pilevari, Azam [4 ]
Mokri, Azarakhsh [1 ]
Mohammadi, Mohammad Reza [1 ,5 ]
Malekinejad, Mohsen [6 ]
机构
[1] Univ Tehran Med Sci, Roozbeh Hosp, Dept Psychiat, Tehran, Iran
[2] Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran
[3] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies INCAS, Tehran, Iran
[4] Kharazmi Univ, Dept Sociol, Karaj, Iran
[5] Univ Tehran Med Sci, Roozbeh Hosp, Psychiat & Psychol Res Ctr, Tehran, Iran
[6] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA
来源
SUBSTANCE ABUSE-RESEARCH AND TREATMENT | 2022年 / 16卷
关键词
Barrier; facilitator; substance use disorder; treatment; review;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
objective:This investigation explored the barriers and facilitators to substance use disorder (SUD) treatment in the integrated paradigm. methods:A search technique for barriers and facilitators of SUD treatment was applied to the PubMed and Web of Science databases to identify relevant systematic reviews. The eligibility criteria included systematic review (SR) or SR plus meta-analysis (MA) articles published before the end of 2021, human research, and the English language. Each of the 12 relevant review articles met the inclusion criteria. AMSTAR was utilised to evaluate the methodological quality of the systematic reviews. results:Two authors analysed 12 SR/SR-MA articles to identify barriers or facilitators of SUD treatment. The cumulative summary results of these 12 evaluations revealed that barriers and facilitators may be classified into 3 levels: individual, social and structural. By analysing these review papers, 37 structural barriers, 21 individual barriers and 19 social barriers were uncovered, along with 15 structural facilitators, 9 social facilitators and 3 individual facilitators. conclusions:The majority of barriers indicated in the review articles included in this analysis are structural, as are the majority of facilitators. Consequently, the design of macro models for the treatment of substance use disorders may yield various outcomes and potentially affect society and individual levels.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field
    Ashford, Robert D.
    Brown, Austin M.
    Curtis, Brenda
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2018, 189 : 62 - 69
  • [22] Treatment for substance use disorders in pregnant women: Motivators and barriers
    Frazer, Zane
    McConnell, Krystle
    Jansson, Lauren M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2019, 205
  • [23] Barriers and facilitators to discharge processes for inpatients with substance use disorders in therapeutic communities
    Poliansky, Nicolas
    Gorlero, Carolina
    Esteban Remesar, Sergio
    Antonaccio, Daniela
    Czapski, Mariana
    Gemini, Damian
    Esther Fernandez, Mama
    [J]. ACTA PSIQUIATRICA Y PSICOLOGICA DE AMERICA LATINA, 2022, 68 (02) : 76 - 94
  • [24] Effectiveness of substance use disorder treatment as an alternative to imprisonment
    Virtanen, Suvi
    Aaltonen, Mikko
    Latvala, Antti
    Forsman, Mats
    Lichtenstein, Paul
    Chang, Zheng
    [J]. BMC PSYCHIATRY, 2024, 24 (01)
  • [25] Effectiveness of substance use disorder treatment as an alternative to imprisonment
    Suvi Virtanen
    Mikko Aaltonen
    Antti Latvala
    Mats Forsman
    Paul Lichtenstein
    Zheng Chang
    [J]. BMC Psychiatry, 24
  • [26] Substance use disorder: Epidemiology, medical consequences and treatment
    Fuster, Daniel
    Zuluaga, Paola
    Muga, Robert
    [J]. MEDICINA CLINICA, 2024, 162 (09): : 431 - 438
  • [27] Health equity in substance use disorder treatment in Kenya
    Kiburi, Sarah Kanana
    Jaguga, Florence
    Atwoli, Lukoye
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [28] Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary
    Nickolas D. Zaller
    Margaret M. Gorvine
    Jon Ross
    Shannon Gwin Mitchell
    Faye S. Taxman
    David Farabee
    [J]. Addiction Science & Clinical Practice, 17
  • [29] Treatment of bacterial meningitis: An overview of Cochrane systematic reviews
    Prasad, Kameshwar
    Karlupia, Neha
    Kumar, Amit
    [J]. RESPIRATORY MEDICINE, 2009, 103 (07) : 945 - 950
  • [30] Psychedelic-assisted treatment for substance use disorder: A narrative systematic review
    Piper, Theodore
    Small, Francesca
    Brown, Sam
    Kelleher, Michael
    Mitcheson, Luke
    Rucker, James
    Young, Allan H.
    Marsden, John
    [J]. ADDICTION, 2025,